Serhii Borsuk

Serhii Borsuk

Auto-generated profile, based on publicly available information

Serhii Borsuk

Zaporizhzhia State Medical and Pharmaceutical University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in Current issues in pharmacy and medicine: science and practice
Verified
Journal Article
Open access
PDF file
YKYe. O. Karpun
Ye. O. Karpun
SBS. O. Borsuk
S. O. Borsuk
LKLudmila Kucherenko
Ludmila Kucherenko
VPVolodymyr Parchenko
Volodymyr Parchenko
About half of the drugs currently produced are chiral compounds, and about 90 % of these compounds are sold as racemates, consisting of an equimolar mixture of two enantiomers. Although they have the same chemical structure, most of the optical isomers of chiral substances show marked differences in biological activity. It is known that the presence of a single asymmetric atom has become almost an integral part of advanced drug design. The aim of this work was to determine the angle of rotation of the polarization plane of solutions of some S-derivatives of 4-R-5-((((3-(pyridin-4-yl)-1H-1,2,4-triazole-5-yl)thio)methyl))-4H-1,2,4-triazole-3-thiols and the establishment of regularities between the structure of the studied molecules and their optical activity. Materials and methods. The subject of the study was 2-[5-R1-4R2-1,2,4-triazole-3-ylthio]-1-aryletanols. The study of the angle of rotation of the plane of polarization of solutions of newly synthesized compounds was carried out using an Atago AP-300 polarimeter and the DFU 2.2.7 physical-chemical analysis method “Optical rotation”. Results. The results of the physical-chemical analysis were carried out that the studied compounds exhibit optical activity. The compound 1-((4-methyl-5-(((3-(pyridin-4-yl)-1H-1,2,4-triazole-5-yl)thio)methyl)-4H-1,2,4-triazole-3-yl)thio)-2-phenylethan-1-ol (+43° [deg∙g/cm3∙dm]). The only levorotatory substance was 1-(4-fluorophenyl)-2-((4-methyl-5-(((3-(pyridin-4-yl)-1H-1,2,4-triazole-5-yl)thio))methyl)-4H-1,2,4-triazole-3-yl)thio)ethan-1-ol with specific rotation [α]D20 = -43° [deg∙g/cm3∙dm]. Conclusions. Studies had shown that 1-(4-fluorophenyl)-2-((4-methyl-5-(((3-(pyridin-4-yl)-1H-1,2,4-triazole-5-yl))thio)methyl)-4H-1,2,4-triazole-3-yl)thio)ethan-1-ol was able to rotate the light polarization plane to the left, which was evidence of the advantage of the S-enantiomer in the racemic mixture, and therefore this compound was considerable interest for further preclinical research. Also, all other analyzed compounds behave as optical isomers.

31 August 2026 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
LKLudmila Kucherenko
Ludmila Kucherenko
VSVladyslav Slobodianyk
Vladyslav Slobodianyk
SBSerhii Borsuk
Serhii Borsuk
OKOlha Khromylova
Olha Khromylova
OBOleksii Bihdan
Oleksii Bihdan
HNHanna Nimenko
Hanna Nimenko
Dimethylaminoethanol (DMAE) and sodium succinate are promising active compounds with demonstrated nootropic and metabolic potential, making their combination a candidate for the development of a novel drug aimed at improving cognitive function and supporting neurometabolic processes. Oral powders in sachet form represent a technologically rational choice for such a formulation, offering precise dosing, stability, and ease of use. However, the development of a high-quality sachet powder requires careful selection of excipients that are fully compatible with the active substances and capable of ensuring optimal physicochemical and organoleptic characteristics of the final product. The aim of the study is to scientifically substantiate and select optimal excipients for an oral powder form containing dimethylaminoethanol and sodium succinate, based on a comprehensive assessment of pharmacotechnological indicators. Materials and methods. Nine powder dosage forms were evaluated using a three-factor Greco-Latin square. Each series containing equal amounts of both active ingredients – dimethylaminoethanol and sodium succinate – in a 1 : 1 ratio. Three levels were studied for each factor: fillers (mannitol, lactose, sucrose), disintegrants/anti-caking agents (croscarmellose sodium, potato starch, magnesium carbonate basic), and solubilizers (PEG 4000, PVP K17, PVP K90). Pharmaco-technological parameters were assessed in duplicate; statistical significance was determined by ANOVA. Results. The optimal formulation – comprising sucrose (86%), magnesium carbonate basic (2%), and polyethylene glycol 4000 (2%) alongside 5% each of the two active substances – demonstrated the best combination of technological performance and consumer acceptability. Conclusions. A rational excipient composition for an oral powder sachet containing dimethylaminoethanol and sodium succinate was established through systematic three-factor experimental design and ANOVA

30 December 2025 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
LKLudmila Kucherenko
Ludmila Kucherenko
DODmytro Okolzin
Dmytro Okolzin
BBBogdan Burlaka
Bogdan Burlaka
SBSerhii Borsuk
Serhii Borsuk
OBOleksii Bihdan
Oleksii Bihdan
IPIvan Pavliuk
Ivan Pavliuk
In modern conditions, in particular, against the background of an increase in the frequency of traumatic injuries to the organs of vision because of hostilities and the influence of professional factors, the development of new ophthalmic dosage forms is of particular relevance. Combined drugs containing several active pharmaceutical ingredients, in particular diclofenac sodium and para-aminobenzoic acid, are considered promising solutions for the treatment of infectious and inflammatory eye lesions. At the same time, the effectiveness and safety of such combinations directly depend on their physicochemical compatibility, which determines the stability of the finished dosage form. The aim of the study is to investigate the thermal stability and possible physicochemical interactions between diclofenac sodium and para-aminobenzoic acid by derivatographic analysis of individual substances and their mixture in a 1:1 ratio. Materials and methods. The objects of the study were the pharmaceutical substances diclofenac sodium, para-aminobenzoic acid and a model mixture of the specified active pharmaceutical ingredients. Thermogravimetric analysis was carried out on a Shimadzu DTG-60 device in thermogravimetric analysis and differential thermal analysis modes in the temperature range of 17–250 °C with a heating rate of 10 °C/min in an air atmosphere. Results. In the process of thermogravimetric research, it was established that diclofenac sodium is characterized by high thermal stability. Para-aminobenzoic acid showed three stages of thermal destruction, but analysis of the mixture in a 1:1 ratio did not reveal the appearance of new thermal effects or shifts in the degradation profiles. Conclusions. The results of thermogravimetric analysis indicate the compatibility of diclofenac sodium and para-aminobenzoic acid in terms of thermal characteristics, which confirms the prospects of their simultaneous use

27 March 2026 in Archive of Ophthalmology and Maxillofacial Surgery of Ukraine
Verified
Journal Article
Open access
PDF file
TTT.YE. Tsybulska
T.YE. Tsybulska
OTO.YU. Titkova
O.YU. Titkova
SBS.O. Borsuk
S.O. Borsuk
Background. The etiology and pathogenesis of myopia remain topical and debatable. According to scientific sources, the levels of retinol, 25-hydroxyvitamin D and tocopherol are inversely related to progressive course of myopia. The aim of the study was to improve the effectiveness of diagnosing the course of myopia by developing a mathematical model to predict the probability of myo­pia progression in childhood. Materials and methods. Thirty-four children (68 eyes) with myopia were examined, of which 16 patients (32 eyes) had progressive myopia, and 18 children (36 eyes) had stable course. The average age of the patients ranged from 11 to 16 years. All of them underwent a standard ophthalmic examination and biochemical study of vitamin levels in oral fluid. Statistical processing of the obtained results was carried out in the Statistica 13 En program. Results. Using ROC analysis, 6 potential predictors influencing the progression of myopia were selected, which inclu­ded indicators of the state of the visual analyzer (according to the fin­dings of ophthalmic examination) and the level of vitamins in the oral fluid. Spearman’s rank correlation analysis established the presence of relationships between ophthalmic indicators and the level of vitamins. To select the most significant features associa­ted with the risk of myopia progression for the model, a stepwise elimination method was used, resulting in the selection of 4 signs: retinol, tocopherol, 25-hydroxyvitamin D, and axial length of the eye. Conclusions. The risk of the probability of myopia progression was determined by the following factors: axial length of the eye, levels of 25-hydroxyvitamin D, retinol and tocopherol in oral fluid. This prognostic model in the practical work of an ophthalmologist will allow us to identify a group of children at high risk of myopia progression and to carry out comprehensive preventive measures in a timely manner.

29 December 2017 in Фармацевтичний часопис
Verified
Journal Article
Closed access
PDF file
LKL. I. Kucherenko
L. I. Kucherenko
IMI. A. Mazur
I. A. Mazur
SBS. O. Borsuk
S. O. Borsuk
Повідомлення 2. Вплив допоміжних речовин на фармако-технологічні показники таблеток L-триптофану з тіотриазоліном, отриманих методом вологої грануляції.Мета роботи. Cтворення нового таблеткового лікарського засобу нейропсихотропної дії на основі L-триптофану та тіотриазоліну. Підбір оптимальних допоміжних речовин (ДР), вивчення їх впливу на стійкість таблеток до роздавлювання, стираність, розпадання, зовнішній вигляд поверхні таблеток L-триптофану та тіотриазоліну після 6-ти місяців зберігання.Матеріали і методи. Діючі речовини – L-триптофан та тіотриазолін у співвідношенні 4:1, ДР (наповнювачі, розпушувачі, зв’язуючі розчини, солюбілізатори). Таблетки пресували методом вологої грануляції. Вплив ДР на таблетки, до складу яких входять L-триптофан та тіотриазолін, вивчали за такими показниками: стійкість таблеток до роздавлювання, стираність, розпадання, зовнішній вигляд поверхні таблеток після 6-ти місяців зберігання. Результати й обговорення. За результатами дисперсійного аналізу було встановлено, що на стійкість до роздавлювання серед зв’язуючих розчинів позитивний вплив має 5 % розчин ГПМЦ; серед розпушувачів – натрій кроскармелоза; серед наповнювачів – суміш МКЦ 101 + крохмаль картопляний + лактоза моногідрат. Найменший вплив на стійкість до роздавлювання таблеток L-триптофану з тіотриазоліном чинить додавання солюбілізаторів.На стираність таблеток L-триптофану з тіотриазоліном серед солюбілізаторів лідером є аеросил ; серед розпушувачів – поліплаздон ХЛ 10.При дослідженні часу розпадання таблеток найбільш значущою є суміш МКЦ 101+ крохмаль картопляний + кальцій дигідрофосфат безводний.На зовнішній вигляд поверхні таблеток після шести місяців зберігання лідерами є натрій крохмальгліколят та суміш МКЦ 101 + крохмаль картопляний + магній карбонат основний.Висновки. Вивчено вплив чотирьох груп ДР на стійкість таблеток L-триптофану з тіотриазоліном до роздавлювання, стираність, час розпадання та зовнішній вигляд поверхні через 6 місяців зберігання. З метою отримання оптимального складу таблеток з L-триптофаном та тіотриазоліном відібрано такі ДР: суміш МКЦ 101 + крохмаль картопляний + магній карбонат основний, натрій крохмальгліколят, 5 % розчин ГПМЦ 5, аеросил, кальція стеарат. При використанні саме цих ДР були отримані таблетки L-триптофану з тіотриазоліном, які відповідають вимогам ДФУ щодо таблеток.